CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
118 hedge funds and large institutions have $396M invested in Cymabay Therapeutics in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
118
Holding in Top 10
6
Calls
$2.79M
Puts
$1.5M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$7.84M | |
| 3 | +$7.79M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.36M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.71M |
Top Sellers
| 1 | -$9.61M | |
| 2 | -$4.55M | |
| 3 | -$4.22M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.93M |
| 5 |
Millennium Management
New York
|
-$3.79M |